Table 3.
Obstacles in the treatment of early Crohn’s disease
❑ Difficulty in obtaining adequate number of patients with truly early disease |
❑ Overlap between early and late mechanisms |
❑ Variability of the clinical, pathological and immunological spectrum of CD |
❑ Lack of reliable biomarkers associated with early or late disease |